Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 -0.07 (-3.63%) Market Cap: 568.03 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.17 GF Score: 55/100

Q3 2024 Pacific Biosciences of California Inc Earnings Call Transcript

Nov 07, 2024 / 09:30PM GMT
Release Date Price: $2.45 (-7.55%)
Operator

Good day and welcome to the Pacbio third-quarter 2024 earnings conference call. All participants will be in listen-only mode. Should you need assistance? Please signal a conference specialist by pressing the star key followed by zero.

After today's presentation, there will be an opportunity to ask questions to ask a question. You may press star then one on your telephone keypad to withdraw your question. Please press star. Then two. Please note this event is being recorded.

I would now like to turn the conference over to Todd Friedman, Senior Director of Investor Relations. Please go ahead.

Todd Friedman
Pacific Biosciences of California Inc - Senior Director of Investor Relations.

Good afternoon and welcome to Pacbio's third quarter, 2024 earnings conference call. Earlier today we issued a press release outlining the financial results we'll be discussing on today's call. A copy of which is available in the investors section of our website at www dot pacb dotcom or it is furnished on form eight K available on the securities and exchange

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot